Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
Atherosclerosis
; 363: 109-116, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36357218
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Cardiovascular Diseases
/
Stroke
/
Percutaneous Coronary Intervention
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Atherosclerosis
Year:
2022
Document type:
Article